comparemela.com

Latest Breaking News On - Aligo quarterly report - Page 5 : comparemela.com

Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | June 7, 2023

Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co Ltd for Use of Aligos Oligonucleotide Platform for the Treatment of Liver Diseases

SOUTH SAN FRANCISCO, Calif., May 12, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | May 12, 2023

Aligos Therapeutics to Present at the SVB Securities Global Biopharma Conference

Aligos Therapeutics to Present at the SVB Securities Global Biopharma Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Aligos Therapeutics to Present Nonclinical and Clinical Data for its Chronic Hepatitis B and NASH Portfolio at AASLD s The Liver Meeting® 2022

Aligos Therapeutics to Present Nonclinical and Clinical Data for its Chronic Hepatitis B and NASH Portfolio at AASLD s The Liver Meeting® 2022
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Aligos Therapeutics to Announce Third Quarter Results November 2, 2022

Aligos Therapeutics to Announce Third Quarter Results November 2, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.